share_log

Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Maintains $1135 Price Target

Moomoo 24/7 ·  Mar 26 09:35

Truist Securities analyst Robyn Karnauskas maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and maintains $1135 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment